Mankind Pharma Q3 Results
- BSE: 543904
- NSE: MANKIND
- ISIN: INE634S01028
- Sector: Biotechnology & Drugs
BSE
2,570.00
26.60 (1.05%)
26.60 (1.05%)Volume98.66 K
Updated: Fri 11 Jul, 2025 | 15:29:51
NSE
2,578.3034.30 (1.35%)
34.30 (1.35%)Volume2.78 M
Updated: Fri 11 Jul, 2025 | 15:58:10
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Mankind Pharma Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 2,592.50 | 2,332.09 | 11.17% | 2,110.18 | 22.86% |
| Depreciation/ Amortization | 192.30 | 105.62 | 82.07% | 109.73 | 75.25% |
| Operating Income | 637.50 | 744.42 | -14.36% | 496.78 | 28.33% |
| Net Income | 380.23 | 653.47 | -41.81% | 453.76 | -16.20% |
| Other Operating Expenses Total | 755.27 | 705.15 | 7.11% | 604.51 | 24.94% |
| Net Income Before Taxes | 497.33 | 849.32 | -41.44% | 562.33 | -11.56% |
| Total Revenue | 3,230.00 | 3,076.51 | 4.99% | 2,606.96 | 23.90% |
| Selling/ General/ Admin Expenses Total | 709.71 | 646.43 | 9.79% | 568.35 | 24.87% |
| Diluted Normalized EPS | 9.44 | 16.28 | -42.01% | 11.31 | -16.53% |